Castle Biosciences, Inc. · NASDAQ:CSTL

Maetzold Derek J sold 14,496 Castle Biosciences, Inc. shares (Form 4)

Traded Nov 2, 2026 · Filed Nov 4, 2026

On Nov 2, 2026, Maetzold Derek J (Director, Pres. & Chief Exec. Officer) sold 14,496 Castle Biosciences, Inc. shares at an average US$36.10 for US$523K under a trading plan, leaving 1,396 shares. Filed Nov 4, 2026 (Form 4).

Sold
14,496 shares
Price
US$36.10 average (US$36.01 to US$36.81)
Value
US$523K
Holding after
1,396 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Pres. & Chief Exec. Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 2, 2026Common StockSale7,555US$36.014,929Direct
Nov 2, 2026Common StockSale2,816US$36.012,024Indirect
Nov 2, 2026Common StockSale2,393US$36.011,721Indirect
Nov 2, 2026Common StockSale1,025US$36.813,904Direct
Nov 2, 2026Common StockSale382US$36.811,642Indirect
Nov 2, 2026Common StockSale325US$36.811,396Indirect

Source

Download original · View original at SEC

Related